University Bridge Fund

Predictive analytics for sustainable smart assets. We provide advanced, big-data analytics to unlock the power of IoT across built assets that offer the ability to deliver ESG commitments, operational efficiencies, climate resilience, and environmental compliance at scale.

Atrian Medical Ltd. is an innovative Irish medical device company focused on resolving Atrial Fibrillation (AF) through a unique approach that targets the cardiac autonomic nervous system. Their technology, developed at the Mayo Clinic, utilizes non-thermal Pulsed Field Ablation (PFA) to disable hyperactive neurons responsible for arrhythmias, offering a more durable solution compared to existing therapies. With over €5M in funding and successful enrollment of 36 patients in First-In-Human trials, Atrian Medical is positioned to disrupt the growing AF market with its novel catheter designs and robust intellectual property.

Axign is a fabless chip supplier serving the worldwide audio markets in consumer and professional audio. Its first product is a breakthrough audio controller chip, that combines benchmark performance with a low bill of materials for audio system manufacturers. The chip is specially suited for active speaker systems in streaming audio devices.

Quantexa News Intelligence provides a news API that allows organizations to identify and monitor risk signals and events from global news content at scale.

Bluedrop Medical have developed a patented system to reduce the burden of diabetic foot ulcers. There are currently almost half a billion diabetics worldwide, and it has been estimated that up to 25% will develop a foot ulcer at some point in their life. Of the millions who develop ulcers worldwide every year, hundreds of thousands will require amputation due to infection. Bluedrop Medical are combining detection technology with the Internet of Things to create a connected health system capable of identifying ulcers early, where they can be treated more effectively and cheaply.

CroíValve is an early stage medical device company based in Dublin, Ireland, focused on developing a minimally invasive solution for severe Tricuspid Regurgitation (TR). The company addresses a significant unmet clinical need, as TR has a higher prevalence than aortic stenosis in individuals over 65 years. Their key product, the CroíValve DUO™ Tricuspid Coaptation Valve System, uniquely combines repair and replacement strategies to effectively tackle the challenges posed by TR. With a strong management team possessing extensive clinical, technical, and commercial experience, CroíValve is positioned to make a significant impact in the structural heart market, particularly as they expand their clinical evidence through studies like the TANDEM II Early Feasibility Study.

Danalto is a system software company based in Ireland that focuses on delivering GNSS denied location services through terrestrial radio resources. Their Cardinal™ Platform enables indoor navigation and location-handover, integrating with existing IT services and providing APIs for enterprises. They are recognized as a leading provider of middleware, cloud, APIs, tools, and analytics solutions for mission-critical spatial applications, enhancing location intelligence for various industries. With contracts from notable clients like the European Space Agency, Danalto is positioned as a key player in the location services market, offering scalable solutions for asset tracking and positioning intelligence.

Founded by experts in quantum physics and semiconductors, Equal1 aims to democratise quantum computing by making it accessible and affordable with its innovative quantum silicon technology. By integrating the entire quantum computing system onto a single chip, Equal1 significantly reduces the size and cost of quantum computers, transforms their performance and scalability, and opens up a world of possibilities in sectors like pharmaceuticals, finance, materials science, and more. Equal1 is supported by funding from Atlantic Bridge (abven.com), Matterwave Ventures (matterwave.vc), Enterprise Ireland (enterprise-ireland.com), European Innovation Council (eic.ec.europa.eu), and 808 Ventures (808ventures.vc).

LUMA Vision, founded in 2017, is a privately held medical device company based in Dublin and Munich, developing innovative imaging technologies for cardiologists. Their flagship product, VERAFEYE, is an end-to-end platform that enhances cardiac imaging, providing accurate and actionable data at the point of therapy. The company operates at the intersection of hardware, software, and machine learning, aiming to improve decision-making accuracy in healthcare. With a focus on addressing global clinical needs, LUMA Vision is positioned as a leader in health-tech innovation, backed by a diverse group of investors and recognized for its entrepreneurial achievements.

Our mission is to improve the world by making lightning-fast suburban deliveries affordable, green, and safe. We're hiring: https://www.manna.aero/careers

Micron Agritech is a multi-award-winning Irish start-up specializing in rapid, pen-side diagnostics for animal health. Their flagship product, the Micron Kit, utilizes AI technology to deliver fast and accurate fecal egg count (FEC) and fluke test results directly to users' phones within minutes, significantly reducing the wait time compared to traditional lab tests. This innovative solution not only enhances the efficiency of veterinary practices but also helps farmers manage parasite resistance effectively, positioning Micron Agritech as a leader in the animal health sector. With a commitment to sustainability and a focus on digital transformation, the company is poised for growth in a market that increasingly demands rapid and reliable diagnostic tools.

Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and safely disrupting hyperactive autonomic nerves that drive underlying inflammation. Their proprietary NEUROMARK® technology enables physicians to precisely target and disrupt multiple underlying nerve branches to alleviate Chronic Rhinitis symptoms, improving patient quality of life. The company is headquartered in Galway, Ireland, with a US office in Boston, MA, and has demonstrated significant clinical improvements in treating chronic rhinitis, positioning itself as a leader in this niche medical device market.